Bill Text: CA AB2984 | 2019-2020 | Regular Session | Introduced
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Prescription drug cost sharing.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2020-05-05 - Re-referred to Com. on HEALTH. [AB2984 Detail]
Download: California-2019-AB2984-Introduced.html
Bill Title: Prescription drug cost sharing.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2020-05-05 - Re-referred to Com. on HEALTH. [AB2984 Detail]
Download: California-2019-AB2984-Introduced.html
CALIFORNIA LEGISLATURE—
2019–2020 REGULAR SESSION
Assembly Bill
No. 2984
| Introduced by Assembly Member Daly |
February 21, 2020 |
An act relating to prescription drugs.
LEGISLATIVE COUNSEL'S DIGEST
AB 2984, as introduced, Daly.
Prescription drug prices.
Existing law authorizes the Department of General Services to enter into exclusive or nonexclusive contracts on a bid or negotiated basis with manufacturers and suppliers of single-source or multisource drugs. Existing law authorizes the department to obtain from those manufacturers and suppliers discounts, rebates, or refunds based on quantities purchased insofar as permissible under federal law. Existing law authorizes those contracts to include price discounts, rebates, refunds, or other strategies aimed at managing escalating prescription drug prices. Existing law requires certain state agencies to participate in that prescription drug bulk purchasing program, including, but not limited to, the State Department of State Hospitals and the State Department of Developmental Services.
Existing law generally prohibits a person who manufactures a
prescription drug from offering in California any discount, repayment, product voucher, or other reduction in an individual’s out-of-pocket expenses associated with their health insurance, health care service plan, or other health coverage, including, but not limited to, a copayment, coinsurance, or deductible, for any prescription drug if a lower cost generic drug is covered under the individual’s health insurance, health care service plan, or other health coverage on a lower cost-sharing tier that is designated as therapeutically equivalent as indicated by the federal Food and Drug Administration, as specified.
This bill would state the intent of the Legislature to enact legislation to make prescription drugs more affordable.
